Cell and gene therapies and radiopharmaceuticals are creating new possibilities for patients, particularly those living with serious diseases and unmet medical needs. Yet the development and delivery of these therapies continue to be shaped by complex and fragmented regulatory approaches.
The first day of the conference will examine existing regulatory frameworks for advanced therapies across the region and consider how greater convergence, reliance, and recognition could support more consistent and efficient regulatory approaches. Regulators and industry experts will identify practical recommendations for future-ready frameworks and discuss how sustained dialogue can support robust regulatory oversight and timely patient access.
The program will also examine the digital transformation of regulatory systems, drawing on perspectives from Asia and Africa to ask: How can regulatory authorities leapfrog through digitalization? Discussions will explore how digital tools, interoperable systems, and new models of collaboration can strengthen regulatory capacity and enable more efficient information-sharing.